NbN Books
NbN Chapters in Books
Books that adapt NbN

Frazer, A., & Blier, P. (2016). A neuroscience-based nomenclature (NbN) for psychotropic agents. International Journal of Neuropsychopharmacology, 19(8).


Krystal, J. H., Abi-Dargham, A., Barch, D. M., Bullmore, E. T., Carter, C. S., Geschwind, D. H., Harrison, P.J., Nestler, E.J. & Stein, M. B. (2016). Biological psychiatry and biological psychiatry: cognitive neuroscience and neuroimaging adopt neuroscience-based nomenclature. Biological psychiatry, 80(1), 2-3.


Möller, H. J. (2016). The new neuroscience based nomenclature of neuropsychotropic drugs: A chance for a better understanding and teaching of clinical psychopharmacology. European Psychiatry, 33(S1), S62-S63.


Möller, H. J., Schmitt, A., & Falkai, P. (2016). Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications. European archives of psychiatry and clinical neuroscience, 266(5), 385-386.


Nutt, D. J., & Blier, P. (2016). Neuroscience-based nomenclature (NbN) for the journal of psychopharmacology. Journal of Psychopharmacology, 30(5), 413-415.


Ramadas, S. (2016). Neuroscience-based nomenclature and medicolegal significance. Indian Journal of Psychiatry, 58(3).


Uchida, H., Yamawaki, S., Bahk, W. M., & Jon, D. I. (2016). Neuroscience-based Nomenclature (NbN) for clinical psychopharmacology and neuroscience. Clinical Psychopharmacology and Neuroscience, 14(2), 115.


Blier, P., Oquendo, M. A., & Kupfer, D. J. (2017). Progress on the Neuroscience-based Nomenclature (NbN) for psychotropic medications. Neuropsychopharmacology, 42(10), 1927-1928.


Brühl, A. B., & Sahakian, B. J. (2017). Neuroscience-based Nomenclature: improving clinical and scientific terminology in research and clinical psychopharmacology. Psychological Medicine, 47(8), 1339-1341.


Caraci, F., Enna, S. J., Zohar, J., Racagni, G., Zalsman, G., van den Brink, W., Kasper, S., Koob, G.F., Pariante, C.M., Piazza, P.V. and Yamada, K., & Drago, F. (2017). A new nomenclature for classifying psychotropic drugs. British journal of clinical pharmacology, 83(8), 1614-1616.


Gorwood, P., Frangou, S., & Heun, R. (2017). Neuroscience-based Nomenclature (NbN) replaces the current label of psychotropic medications in European Psychiatry. European Psychiatry, 40, 123-123.


Stahl, S. M. (2017). Neuroscience-based nomenclature: classifying psychotropics by mechanism of action rather than indication. Current Psychiatry, 16(5), 15-16.


Kikuchi, Y., Zohar, J., Suzuki, T., Mimura, M., Yagi, G., & Uchida, H. (2018). Mood stabilizers as an Achilles’ heel for indication‐based nomenclature and roles of Neuroscience‐based Nomenclature. Psychiatry and Clinical Neurosciences, 72(12), 854-855.


Wilson, S. (2018). Naming the drugs we use: neuroscience-based nomenclature, a helpful innovation. Therapeutic Advances in Psychopharmacology, 8(6), 171-172.


Uchida, H. (2018). Neuroscience‐based Nomenclature: What is it, why is it needed, and what comes next?. Psychiatry and Clinical Neurosciences, 72(2), 50-51.